当前位置:首页 - 行情中心 - 海特生物(300683) - 财务分析 - 资产负债表

海特生物

(300683)

  

流通市值:28.69亿  总市值:30.81亿
流通股本:1.22亿   总股本:1.31亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金463,292,993.72510,216,050.96482,790,575.72393,341,805.28
应收票据及应收账款55,709,195.2861,136,206.9950,342,978.5452,711,939.87
其中:应收票据5,456,138.888,225,006.3--
应收账款50,253,056.452,911,200.6950,342,978.5452,711,939.87
应收款项融资12,598,715.8215,214,650.3319,259,575.422,813,592.84
预付款项16,284,216.567,434,025.3424,519,504.1930,044,112.49
其他应收款合计5,630,998.953,863,118.733,866,360.133,415,426.33
存货118,992,000.77117,414,218.43147,557,414.36146,475,057.3
合同资产189,868,323.7178,230,129.79177,280,337.99170,175,208.69
其他流动资产22,542,883.515,984,110.1721,684,939.6323,574,425.48
流动资产平衡项目0000
流动资产合计1,470,633,737.371,488,199,258.131,588,041,406.571,632,453,652.32
非流动资产:
债权投资--51,500,00048,000,000
长期股权投资21,868,260.1922,078,771.8543,547,000.7544,358,270.27
其他权益工具投资5,000,0005,000,0005,000,0005,000,000
投资性房地产313,897.94319,972.94326,047.94332,122.94
固定资产714,474,217.04717,693,631.51577,154,527.36558,378,734.21
在建工程3,783,253.332,994,021.52130,670,871.82123,726,842.3
使用权资产12,772,169.8113,871,808.745,517,524.66,082,928.3
无形资产271,424,087.21276,880,214.7285,553,959.8687,167,525.38
开发支出20,811,278.9421,784,776.853,224,4001,856,290.86
商誉263,591,202.15263,591,202.15302,151,453.39302,151,453.39
长期待摊费用11,457,986.3610,180,044.87706,828.361,346,601.46
递延所得税资产120,939,020.72109,471,792.69100,452,850.3692,127,244.66
其他非流动资产48,270,401.4539,185,660.6533,026,988.6836,904,370.28
非流动资产平衡项目0000
非流动资产合计1,494,705,775.141,483,051,898.491,338,832,453.121,307,432,384.05
资产平衡项目0000
资产总计2,965,339,512.512,971,251,156.622,926,873,859.692,939,886,036.37
流动负债:
短期借款7,335,672.247,323,320.6810,000,000-
应付票据及应付账款41,744,622.4352,078,939.7139,474,767.342,562,161.39
应付账款41,744,622.4352,078,939.7139,474,767.342,562,161.39
合同负债122,191,217.83115,999,340.34121,542,191.81129,487,103.69
应付职工薪酬14,939,948.7240,813,730.6724,137,535.9716,945,503.34
应交税费4,647,790.335,660,340.634,356,091.425,022,256.38
其他应付款合计94,586,831.7295,883,819.9838,235,743.7938,431,380.13
一年内到期的非流动负债22,456,381.3421,911,625.9816,336,475.113,780,082.48
其他流动负债3,131,374.846,474,886.94876,028.6959,929.5
流动负债平衡项目0000
流动负债合计311,033,839.45346,146,004.93254,958,833.99247,188,416.91
非流动负债:
长期借款22,666,932.9126,316,932.9129,966,932.9133,616,932.91
租赁负债9,244,556.1310,403,799.414,393,015.394,658,735.99
长期应付款45,915,572.7545,915,572.752,451,3002,451,300
递延收益81,641,866.8630,467,562.4128,771,118.7229,244,339.73
递延所得税负债16,738,243.9516,480,449.3912,184,587.511,779,190.52
非流动负债平衡项目0000
非流动负债合计176,207,172.6129,584,316.8777,766,954.5281,750,499.15
负债平衡项目0000
负债合计487,241,012.05475,730,321.8332,725,788.51328,938,916.06
所有者权益(或股东权益):
实收资本(或股本)130,894,391130,894,391130,894,391130,894,391
资本公积1,836,988,950.911,836,919,613.311,836,919,613.311,836,919,613.31
盈余公积53,264,178.8353,264,178.8353,264,178.8353,264,178.83
未分配利润440,531,562.32457,077,087.7551,460,436.01566,772,175.17
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,461,679,083.062,478,155,270.842,572,538,619.152,587,850,358.31
少数股东权益16,419,417.417,365,563.9821,609,452.0323,096,762
股东权益平衡项目0000
股东权益合计2,478,098,500.462,495,520,834.822,594,148,071.182,610,947,120.31
负债和股东权益合计2,965,339,512.512,971,251,156.622,926,873,859.692,939,886,036.37
公告日期2024-04-222024-04-222023-10-252023-08-31
审计意见(境内)标准无保留意见
TOP↑